Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB25FCMZH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,181
Award facts
- Contract value 100% obligated
- $26,181.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $26,181 by the Defense Logistics Agency on September 3, 2025, for the supply of PRIVIGEN 10% vial 200mL. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a specific pharmaceutical product requisition under DMS Pharmaceutical Group's larger relationship with DLA. The award carries no set-aside designation, indicating the contractor competed on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables DLA to issue firm fixed-price delivery orders across a comprehensive range of pharmaceutical products supporting medical supply needs of military health facilities worldwide. PRIVIGEN, an intravenous immunoglobulin therapy, falls within the biologics category of products covered under this broader contract vehicle. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a consistent portfolio of delivery orders for branded medications, generic drugs, vaccines, and specialty pharmaceutical products serving Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FCMZH?
SPE2DB25FCMZH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FCMZH worth?
The government has obligated $26,181 on SPE2DB25FCMZH.
Is contract SPE2DB25FCMZH an order under another contract?
Yes. SPE2DB25FCMZH is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZH competed?
The extent of competition for SPE2DB25FCMZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award